Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fondaparinux vs Enoxaparin for VTE Prophylaxis in Vascular Surgery Inpatients
ChiCTR2000035142Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in venous thromboembolism (VTE) comparing Fondaparinux arm with Enoxaparin arm (2 arms). Primary endpoints: Thrombotic events and Bleeding events. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
fondaparinuxenoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ChiCTR2000035142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035142.